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Abstract
Osteoporosis is a prevalent condition that is often overlooked until a fragility fracture occurs.
Screening for bone loss with dual-energy X-ray absorptiometry (DXA) scans is underutilized in
the primary care setting. Direct communication with at-risk patients, offering self-referral for
DXA screening, has been demonstrated to be the most effective intervention in increasing DXA
screening rates. The goal of this DNP project was to improve bone density screening rates in a
primary care practice by inviting patients at greatest risk of osteoporosis to schedule a DXA
without a provider order. After a review of the electronic medical record, letters and educational
brochures were mailed to 261 eligible patients, including women age 50 and over and men age
70 and over, with instructions to schedule a DXA scan. Sixty-seven (25.6%) patients completed
a DXA scan within three months of receiving the letter. Patients whose DXA results revealed
osteoporosis or osteopenia with a high risk of fracture were invited for in-person educational
counseling and medication management. Number of correct items on an abbreviated version of
the Osteoporosis Knowledge Assessment Tool (OKAT) tool improved from 5.55 (SD 3.3) before
counseling to 10.18 (SD = 2.2) after counseling. Three months after the intervention, 475
(66.3%) of patients in the practice were appropriately screened for osteoporosis, compared with
398 (55.6%) three months prior to the intervention. The implication for nurse practitioners is the
need to advocate for primary and secondary prevention of osteoporosis as well as educate
themselves about screening guidelines, lifestyle recommendations and medication options for
treating osteoporosis.

Keywords: osteoporosis, bone density, DXA, screening, self-referral, older adults
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Improving Osteoporosis Screening Rates in a Primary Care Practice
Introduction
Low bone mass, a widespread condition mainly affecting older people, is asymptomatic
until a fracture occurs. Worldwide, an estimated 10.2 million adults had osteoporosis and 43.4
million had osteopenia in 2010 (Wright et al., 2014). The only symptom of low bone density is
fracture, which is a major cause of disability and deconditioning in older adults. Due to an aging
population, the incidence of fractures is estimated to grow to more than three million per year by
2025 and will incur $25.3 billion in costs by that year (Burge et al., 2007). The one-year
mortality rate for elders after a hip fracture is 20%, and this rate has not decreased in the past 30
years despite surgical advances (Mundi, Pindiprolu, Simunovic, & Bhandari, 2014). If using the
National Osteoporosis Foundation (NOF) guidelines, as many as 30% of women over 50 and
19% of men over 50 are at sufficient risk for fracture to justify osteoporosis medication
(Dawson-Hughes et al., 2012). Failure to detect bone loss and lack of treatment prior to a
fracture are missed opportunities; a meta-analysis of multiple drug trials confirms that several
agents have demonstrated a reduced risk of fractures when compared to placebo in both men and
women (MacLean et al., 2008; Nayak & Greenspan, 2017).
Background
Osteoporosis is a silent disease, and screening for bone loss can identify patients at
increased risk of a fragility fracture, which is one that occurs with minimal trauma. Imaging with
dual-energy X-ray absorptiometry (DXA) at the hip and lumbar spine is the gold standard for
osteoporosis screening (Cosman et al., 2014; US Preventative Services Task Force [USPSTF],
2018). With the identification of bone loss, healthcare providers can make lifestyle
recommendations and prescribe medication to halt or reverse bone loss and prevent a fracture.
Since patients often underestimate their own fracture risk (Grover et al., 2014), it is important for
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healthcare providers, especially in the primary care setting, to initiate the identification of
patients at risk for fracture. A literature search was conducted to elucidate the best practices of
bone density screening and strategies for adhering to these guidelines.
The rates of DXA screening in clinical practice remain suboptimal. In one study of
women aged 50 and over with no prior diagnosis of bone loss, screening rates were calculated
over a two-year period using claims data (Gillespie & Morin, 2017). For women aged 50 to 64,
21.1% were screened, 26.5% of women aged 65 to 79 were screened, and 12.8% of those aged
80 and above were screened (Gillespie & Morin, 2017). Amarnath, Franks, Robbins, Xing, and
Fenton (2015) showed that rates of DXA screening in primary care reflected both
underutilization and overutilization of bone density screening. Over a seven-year period,
cumulative incidence of bone density screening was 58.8% among women aged 60 to 64 years
with one or more risk factors, 57.8% for women aged 65 to 74 years, and 42.7% for women age
75 years and over. DXA screening was done for 45.5% among women aged 50 to 59 years
without risk factors and 58.6% among women aged 60 to 64 years without risk factors
(Amarnath et al., 2015). Bone density screening rates for men, which have been studied less
frequently than for women, are even lower. In a sample of men aged 70-75, about 18% had a
DXA in their lifetime (Alswat & Alder, 2012).
Problem Statement
Osteoporosis among adults over 50, a risk for fragility fracture without prior symptoms,
is indicated by bone loss that results from normal aging and several secondary risk factors;
currently adults at risk for bone loss are not optimally screened with DXA scans, preventing
appropriate lifestyle and medication recommendations prior to a potential fracture. This quality
improvement project seeks to identify primary care patients at risk for bone loss who are
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candidates for osteoporosis screening and offer a DXA scan to these patients. The ultimate goal
of the project is to provide intervention to patients at risk of fracture in order to prevent a
fragility fracture.
Organizational “Gap” Analysis of Project Site
This project took place at an internal medicine practice located in eastern MA that is
affiliated with a nearby community hospital. According to the hospital’s population health
software analyzing the practice’s electronic medical record (EMR) data, the DXA screening rate
at the practice is currently around 19%; this includes 1) women 65 and over, 2) men 70 and over
and 3) adults with a history of fragility fracture over age 50 who have had DXA in the last two
years (Hospital Electronic Medical Record, 2019). This is roughly on par with national screening
rates of 12.8 to 26.5% for women (Gillespie & Morin, 2016) and 18% for men (Alswat & Adler,
2012). Presently, there is no systematic screening for secondary risk factors for osteoporosis, and
osteoporosis is not a focus of the quality improvement efforts of the hospital’s population health
team. In the health maintenance screen of the hospital’s EMR, there is a field in which a date can
be entered for bone density tests, but this is only in the charts of females. There are no reminders
in the EMR to complete a DXA.
Review of the Literature
In compiling evidence for the topic of osteoporosis screening and related interventions,
the Cumulative Index to Nursing and Allied Health Literature (CINAHL) and PubMed databases
were utilized. The search terms included “osteoporosis AND screening AND primary care,”
“osteoporosis AND screening AND electronic AND record,” “bone density AND screening
AND primary care,” “DXA AND screening AND primary care,” “DEXA AND screening AND
primary care,” and “FRAX and United States.” The database search excluded articles prior to the
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last 10 years and was limited to the English language. In both databases, the age range was
limited to adults age 45 and over. The Johns Hopkins Nursing Evidence Based Practice
(JHNEBP) evidence rating scales (Newhouse, Dearholt, Poe, Pugh, & White, 2005) were used
for grading the quality and strength of the evidence.
The search yielded 637 articles, out of which 88 articles and ten clinical guidelines were
chosen to review. Out of the 88 articles, 13 were selected citations of relevant studies, some
more than 10 years old, located in the reference sections of articles located in the databases.
Preference was given to studies from the United States in order to review healthcare utilization in
context of the American healthcare system. Studies rated as Level I, II and III evidence were
included, with an emphasis on meta-analyses and systematic reviews; these included high-quality
studies with large sample sizes and well-defined methods. Papers demonstrating Level IV and V
evidence were excluded. Other common reasons for exclusion included focus on special
populations or secondary causes of osteoporosis, focus on imaging technology itself, and focus
on treatment rather than screening. In preparing a synthesis of the literature, each of the papers
was evaluated, using the Matrix Method (Garrard, 2017), in terms of description of the study
sample, location of the study, design, intervention method, outcome, strengths, limitations, and
level of evidence.
Of the 87 studies critiqued, 39 were included in the review. Of the 10 guidelines, seven
were published in a peer-reviewed journal articles, which were reviewed and compared using the
Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument. This tool analyzes
the six quality areas of a clinical guideline, including scope and purpose, stakeholder
involvement, rigor of development, clarity of presentation, applicability, and editorial
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independence (AGREE, n.d.). The guidelines with the three highest overall scores were used in
determining the DXA screening criteria applied to this project.
Best Screening Practices
Unfortunately, making clinical decisions about which patients to screen for bone loss is
not always straightforward. Several national and international guidelines for osteoporosis
screening exist, but they make slightly different recommendations (see Appendix A). They
mainly agree that all women aged 65 and over should be screened, as well as postmenopausal
women age 50-64 with at least one risk factor for osteoporosis. The National Osteoporosis
Foundation, the Endocrine Society, the American College of Preventative Medicine (ACPM) and
the International Society for Clinical Densitometry (ISCD) all recommend screening men age 70
and over regardless of risk factors (Cosman et al., 2014; ISCD, n.d.; Lim et al., 2009; Watts et
al., 2012). However, the USPSTF and American Academy of Family Physicians (AAFP) assert
that there is insufficient evidence to support screening in men (AAFP, 2017; USPSTF, 2018).
The American College of Physicians (Qaseem et al., 2008) recommends screening men only if
risk factors are present. The American College of Gynecology (ACOG), the North American
Menopause Society and the American Academy of Clinical Endocrinologists / American College
of Endocrinology (AACE / ACE) guidelines all address bone loss in women only (Camacho et
al., 2016; Committee on Practice Bulletins - Gynecology, 2012; North American Menopause
Society, 2010).
According to a comparison using the AGREE tool, the three guidelines that were
developed with the most rigor were those of the Endocrine Society, AACE/ACE and the
USPSTF. The Endocrine Society and USPSTF guidelines contradict each other on whether
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screening in men is indicated. Clearly more research needs to be conducted regarding bone loss
in men in order to develop more definitive osteoporosis screening guidelines for men.
In men and women alike, assessing risk for fracture is rather complex. While there are
references of dozens of risk factors for osteoporosis in the literature (Cosman et al., 2014),
several key factors are identified by the World Health Organization’s (WHO) Fracture Risk
Assessment (FRAX) tool as the most important in predicting fracture risk. The FRAX tool was
developed to calculate 10-year risk of major osteoporotic and hip fractures using femoral neck
scores on DXA and the presence of several risk factors. These include previous fragility fracture,
low body mass index (BMI), a parental history of hip fracture, current smoking, alcohol intake of
three or greater drinks per day, lifetime exposure to oral steroids for three months or longer, a
diagnosis of rheumatoid arthritis, and secondary causes of osteoporosis. Secondary causes
identified are type I diabetes, osteogenesis imperfecta in adults, untreated long-standing
hyperthyroidism, hypogonadism or premature menopause (age less than 45 years), chronic
malnutrition, or malabsorption and chronic liver disease (Jiang et al., 2017).
Although FRAX is studied globally and is commonly used in clinical practice, it has
lower sensitivity in predicting fracture than simpler risk assessment tools. Crandall et al. (2014)
found that the sensitivity of the FRAX (without bone density measurements) for younger
postmenopausal women was as low as 34%. For women over 65, the FRAX overestimates 10year fracture risk (Hillier et al., 2011). Additionally, for men age 65 and over, the FRAX has
either underestimated (Diem et al., 2012; Ensrud et al., 2014) or overestimated risk of fracture
(Ettinger et al., 2013). A systematic review of fracture risk assessment instruments demonstrates
that simpler instruments with less than five variables perform as well as those with greater than
five variables (Nayak, Edwards, Saleh, & Greenspan, 2014). According to a meta-analysis by the
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same group, Osteoporosis Self-Assessment Tool (OST), the Simple Calculated Osteoporosis
Risk Estimation (SCORE) instrument, the Osteoporosis Risk Assessment Instrument (ORAI),
and body weight criteria all have sensitivities near or exceeding 90% (Nayak, Edwards, Saleh, &
Greenspan, 2015). However, the sensitivities are generally lower for younger than older
participants (Nayak et al., 2015). Of note, the trade-off of these high-sensitivity instruments is
low specificity.
The OST, validated in postmenopausal women (Geusens et al., 2002) and older men
(Adler, Tran & Petkov, 2003), is the simplest of these validated risk assessment tools in that it
accounts for only three variables: weight, sex and age. It is comparable or superior in sensitivity
of other fracture risk assessment tools in postmenopausal women (Rud, Hilden, Hyldstrup, &
Hróbjartsson, 2009). A systematic review by Liu et al. (2008) confirms that BMI 20-25 and age
70 and over are the most important risk factors for fracture in men. Using age and BMI is the
most feasible for a population screening intervention, as opposed to a more complex tool with
several variables. A study of an EMR database of over 50,000 postmenopausal women revealed
that, except for age and BMI, FRAX risk factors were not reliably recorded in the EMR (LaFleur
et al., 2011).
Interventions to Increase Bone Density Screening
History of fracture is a significant risk factor for future fractures (Kanis et al., 2004), and
thus the period immediately following a fragility fracture is often used as an opportunity to
intervene in order to prevent future fractures. A widely-studied intervention model is the fracture
liaison service, a type of secondary fracture prevention. This model involves a dedicated
clinician other than the primary care provider (PCP) receiving an alert of a fragility fracture
during the period of acute fracture treatment, then assessing and treating patients for osteoporosis
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as part of a comprehensive service. In a meta-analysis of fracture liaison service studies, Wu et
al. (2018) showed an approximate 27% increase in the likelihood of bone density testing and up
to a 21% increase in treatment initiation compared with usual care — a referral from the PCP.
Fewer studies examine interventions including adults who have never had a fracture, but
the literature is growing. Lawrence et al. (2017) studied a comprehensive service similar to the
fracture liaison service, but targeted toward those at risk who have never fractured. A Bone
Health Team (BHT) coordinated screening, diagnosis, medication and lifestyle interventions, and
follow-up of men aged 70 and older and women aged 65 and older in seven Veterans Affairs
(VA) outpatient clinics. Fifty-one percent of those receiving care by the BHT had a DXA,
compared to 1.9% in usual care.
In terms of simpler interventions aimed at primary prevention, the use of clinical decision
support (CDS) for providers has been utilized in prompting clinicians to order DXA scans
through electronic medical record (EMR) reminders. However, evidence does not convincingly
show that EMR reminders are effective at increasing bone density screening rates. DeJesus et al.
(2012) showed a modest improvement in DXA completion rates after a CDS tool was
implemented; the rate increased from 80% to 84% completed. The large baseline percentage of
80% completion, however, seems to indicate that this sample may not be widely generalizable.
El-Kareh et al. (2011) showed that an EMR reminder had low yield for successfully leading to a
DXA order, even if there was a link to a computerized order entry screen. In a study of
rheumatology providers, EMR reminders tailored to include patient risk factors did not improve
screening rates (Rolnick, Jackson, & Amundson, 2009).
The literature suggests that contacting at-risk patients directly is more likely to improve
screening rates than systematically reminding providers to order DXA scans. Zhang and Fish
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(2012) demonstrated that patient reminder letters for preventative services, including DXA
scans, improved completion rates from 45% to 66% after two reminder letters were sent. Loo et
al. (2011) showed that EMR alerts alone made no significant difference in bone density
screening rates (19.7% in EMR group vs. 17.7% of patients receiving usual care), while
combining the EMR alert with a phone call or letter to the patient resulted in a screening rate of
30.5%. Another study showed that mailing a letter to women eligible for bone density screening
resulted in 24% of the recipients scheduling DXA scans (Kesman, Rahman, Lin, Barnitt &
Chaudhry, 2010). Of note, these women were appropriately screened; of those who had DXA
scans for the first time, 41% had a new osteoporosis diagnosis and 41% had a new osteopenia
diagnosis.
Studies also showed DXA screening rates improve if, once letters are mailed to eligible
patients, these patients are free to call to schedule a test without an order from the PCP; selfreferral or self-scheduling gives more control to the patient (Ayoub, Newman, Blosky, Stewart,
& Wood, 2009; Denberg et al., 2009; Lafata et al., 2007; Warriner et al., 2012; Warriner et al.,
2014). In a randomized control trial (RCT) studying 10,354 women age 65-89, Lafata et al.
(2007) demonstrated an increase in screening rates from 10.8% to 24.1% after a mailed
reminder. Screening rates increased slightly with an addition of a physician prompt (in the form
of a letter one month later) to 28.9%, but the prompt did not significantly increase treatment rates
compared with a mailed reminder only (Lafata et al., 2007).
Adding a phone reminder has also been shown to augment the effect of a letter. Denberg
et al. (2009) showed that one large practice’s screening rates increased from 60.9% to 78.7%
after 564 eligible women age 65-79 were mailed a reminder letter to schedule a DXA scan;
nearly 50% scheduled a DXA after one letter and up to three reminder calls over a seven-month
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period. In a similar scale study, Ayoub et al. (2009) showed DXA rates of older women were
39.6% after a letter and follow-up call three weeks later, compared to 13.2% for usual care.
Warriner et al. (2012) performed a RCT studying 2997 women over 65 who had no DXA
in at least four years; the intervention was a mailed letter with an educational brochure. The
DXA completion rate for the intervention group was 17.3% compared to 5.2% in the usual care
group. In an even larger RCT, Warriner et at. (2014) studied DXA rates in over 12,000 women
over 65 who had not had a DXA in five years. After a letter with an invitation to self-refer for
DXA, 24.1% of women in the self-refer group completed a DXA, compared to 5.9% in the usual
care group. A meta-analysis of quality improvement strategies to improve osteoporosis care
confirms that self-referral with patient education is the most effective approach to increase
screening rates for those without prior fracture (Nayak & Greenspan, 2018).
Evidence Based Practice: Verification of Chosen Option
Bone density screening is an important component of preventative care that has been
underutilized. Quality improvement efforts to improve DXA utilization have included reminders
to clinicians and outreach efforts to eligible patients. It can be argued that the self-referral
protocol has been feasible with mammography and this is a promising strategy for increasing the
uptake of DXA screening. Decreasing administrative complexity and allowing patients to
schedule DXA without an order from a healthcare provider is low-risk, low-cost and effective.
Combining a patient letter with reminder call and patient education has been more effective than
a letter alone.
Large-scale studies in improving bone density screening rates have included women over
65, the population that guidelines agree is eligible for a DXA. This population should be targeted
in this quality improvement initiative by reaching out to those who have never had a DXA. As
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guidelines suggest, women aged 50-64 should be screened for bone loss if risk factors are
present. Women in the practice age 50-64 with a score on the OST less than 1.0, indicating
moderate (-3 to 1) or high risk (-20 to -4), should also be invited for screening (Geusens et al.,
2002). In postmenopausal women, the OST score less than 1 has a sensitivity of 89% and a
specificity of 41%, while in older men the tool had a sensitivity of 89% and a specificity of 55%
with a cutoff score of 3.0 (Nayak et al., 2015). Although guidelines are mixed about the inclusion
of men in population screening for osteoporosis, a conservative approach is to include the oldest
men at greatest risk. Men age 70 and over should be targeted for screening with an OST score
less than 3. Lastly, adults with diagnosed bone loss need to be invited for screening if their last
DXA scan was greater than five years ago. Although there are no consistent guidelines for DXA
intervals in patients with diagnosed bone loss, Gourlay et al. (2012) showed that 10% of women
(a statistically significant threshold) with moderate osteopenia developed osteoporosis within
five years.
Theoretical Framework/Evidence Based Practice Model
The Stetler Model provides the theoretical underpinnings for this project (Appendix B).
In 2001, the Stetler Model, a research utilization model, was updated within the context of
evidence-based practice (Stetler, 2001). The newer model consists of five phases: preparation,
validation, evaluation/decision making, translation/application and evaluation. In the preparation
phase, one searches for, sorts, and selects sources of research evidence, while in the validation
phase the research evidence is either deemed applicable or is rejected. The comparative
evaluation/decision making phase occurs after synthesizing research evidence and involves
determining feasibility and fit with one’s current practice. This project has undergone these five
phases. Evidence from the body of research has been gathered, included as supportive evidence
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or excluded, and its applicability to a real-world practice has helped shape an idea for a formal
application. Phase 4 entailed a tangible translation/application of the research findings, in the
form of carrying out the intervention, and then an evaluation of the progress made (phase 5). In
evaluating the outcomes, a decision can be made about how this intervention can become a part
of routine practice.
Methods
Goals, Objectives and Expected Outcomes
The main goal of this quality improvement (QI) project was to increase DXA screening
rates in the practice by 25% over the course of three months. It was expected that greater than
50% of the DXA scans completed would reveal a diagnosis of osteopenia or osteoporosis. For
those who receive in-person counseling about bone loss, there would be a 100% improvement
from pre-visit to post-visit scores on the Osteoporosis Knowledge Assessment Tool (OKAT)
(Winzenberg, Oldenburg, Frendin, & Jones, 2003), reflecting increased knowledge of lifestyle
changes in halting bone loss and preventing fractures. After patient counseling on the results of
the scans, the aim was for >50% of applicable patients to begin osteoporosis medication
treatment. While it was not a main outcome measure, increased numbers of osteoporosis
medication prescriptions during the course of the project may reflect enhanced patient
understanding of fracture risk. The ultimate objective of this project was to decrease fragility
fractures, but this cannot be measured in the scope of this project.
Project Design
This QI project was a practice intervention in the form of a population screening. It used
a one group, pre- and post-intervention design. The first phase of the intervention is a mailing of
an invitation letter and education brochure, while the second phase is follow-up counseling for
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patients who qualify for osteoporosis medication.
Project Site and Population
The project setting was an outpatient primary care office in eastern MA. The practice
employs three physicians and one nurse practitioner, who is the DNP student conducting this
quality improvement project. Other onsite staff included one licensed practical nurse, three
medical assistants, two office coordinators and one office manager. The practice performs an
average of 26 patient visits per day. There are 213 patients with diagnosed osteopenia, 45 with
osteopenia and high risk of fracture and 143 with osteoporosis.
Although the office had a DXA scanner until 2017, its providers have since referred
patients to its affiliated hospital, six miles away, for DXA screening. Alternatively, patients
could have had DXA screening at either of two hospital-affiliated outpatient health centers; these
are respectively 10 miles northwest and 14 miles southwest of the office.
Project Implementation and Data Collection Procedure
This QI project is divided into two phases that are referred to as Phase I, mailing of
patient DXA invitation and education, and Phase II, patient medication and lifestyle counseling.
Phase I. The DNP student extracted EMR data to determine which patients were eligible
for bone density screening. Patients were selected from patient lists provided by the hospital
information technology (IT) department staff and population health team. The hospital IT
department generated four lists using the IBM Watson tool with the filters: 1) females over 65
without a DXA scan in the last 5 years, 2) male patients over 70 without a DXA in the last 5
years, 3) all female patients age 50-64, and 4) male and female patients with a diagnosis of
osteoporosis or osteopenia coded in the EMR. The IT department then provided lists of 1) all
female patients age 50 and over (born on or before September 1, 1969) and 2) all male patients
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age 70 and over (born on or before September 1, 1949). Age-based lists were needed to
determine the ratio of appropriately screened patients compared with the total number who
should have been screened. These lists were imported into a Microsoft Excel document and
placed into tabs by eligibility criteria. Names were cross-referenced and duplicates removed.
Also removed were patients who had left the practice, were deceased, lived in long-term care, or
were receiving hospice care.
Prior to the mailing intervention, potential participants were classified as eligible or noneligible. Eligible participants made up four groups: 1) Women age 65 and over with no history of
DXA scan, 2) Postmenopausal women age 50-64 with OST score less than 1.0 and no DXA in
the last five years, 3) Men age 70 and over with an OST score less than 3.0 and no DXA in the
last five years, 4) Men and women age 50 and over with prior DXA with lumbar, total hip or
femoral neck T-score of -1.0 or lower (indicating osteopenia or osteoporosis) and no DXA in the
last five years. During the chart reviews, two additional eligibility criteria were added: 1) a
history of fracture after age 50 and no DXA in the last five years and 2) evidence of osteopenia
on an x-ray or CT scan and no DXA in the last five years. Exclusion criteria included: evidence
of a DXA scan in the last five years, residence in long-term care facility, receiving hospice
services, premenopausal or perimenopausal status, and inactive status in the practice (evidence
that the patient left the practice or were not seen in greater than three years).
For each patient, weight in pounds, as close to the start date of the intervention as
possible, was recorded in the database. The weight was converted into kilograms using a
mathematical function in Excel. Age at the day of the start of the intervention was calculated
using the formula (10/15/19 - date of birth). OST scores were calculated by another
mathematical function: 0.2 x (weight in kilograms - age in years). Men over 70 with OST scores
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greater than 3.0 were marked ineligible, as well as women 50-64 with an OST score greater than
1.0. Also marked ineligible were women whose chart showed evidence of perimenopausal or
premenopausal status. All women age 65 and over without prior history of a DXA scan were
considered eligible; their eligibility was not affected by OST scores.
For all patients with prior record of a DXA scan, dates of prior DXA scans, T-scores
from these scans as well as history of treatment was ascertained from the EMR. This EMR
review determined the baseline number of patients in the practice who were appropriately
screened three months prior to the intervention.
Any patient with a DXA scan within the last 5 years was marked ineligible. However, for
both eligible and ineligible patients, most recent DXA scan results were recorded in T-scores of
the lumbar spine and hip, when available. For the purpose of verifying diagnoses, FRAX scores,
which predict 10-year major fracture and hip fracture, were recorded. If not already recorded in
the patient’s chart, the scores were calculated using the FRAX tool (University of Sheffield,
n.d.). Diagnosis of bone loss was verified on the patients’ EMR problem lists and either added or
corrected if needed. In order to find DXA scans of many of the newer patients in the practice, the
DNP student gained permission to access a neighboring hospital’s electronic medical record
system.
Each of the practice’s PCPs reviewed lists of their eligible patients to exclude any
patients they did not wish to receive a letter. Some reasons cited were memory loss, history of
medication noncompliance, poor renal function functioning, and advanced age. After the list of
284 eligible patients was finalized, the DNP student drafted and printed DXA orders from the
EMR. An ICD-10 diagnosis code was as specific as possible to give support for insurance
coverage of the DXA scan. If osteopenia, osteoporosis, osteopenia on x-ray, or fracture was not
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on the problem list, then clinical diagnoses were chosen such as cigarette smoking, early
menopause or rheumatoid arthritis as these are risk factors for bone loss. Otherwise, the
diagnosis “screening for osteoporosis” was used. Four days prior to mailing the letters, the DNP
student delivered orders for DXA scans for all eligible patients to the scheduling department.
Drafting and mailing invitation letters and educational brochures was done by the DNP
student. Content of the mailing, including a form letter (Appendix C) and an educational
brochure (Appendix D). The form letter was written by the DNP student with help of the DNP
project mentor and edited by the marketing team. As requested by the marketing team, letters
were printed on color hospital letterhead. The brochure was drafted using principles outlined by
Edmonds et al. (2017), which examined the preferences of older adults in different types of
osteoporosis educational brochures; the study showed that the participants preferred photographs
as opposed to drawings, large print and plain language, avoiding medical jargon. Participants
also preferred photos of people of diverse ages and race/ethnicity and limiting photos to one per
page. The letter and brochure were approved by the DNP project mentor, director of radiology,
and the hospital’s marketing department, who printed the brochures with a hospital logo.
Templates of the DXA invitation letter and the DXA results letter were uploaded to the
EMR by a member of the information technology department. The DNP student printed the
patient invitation letters, saving a copy in the electronic medical record as a document. A “care
alert” note was placed in the EMR charts of eligible patients so that prompting by providers and
staff members during office visits and phone calls was possible during the three-month period of
the intervention. The reminder was set to expire January 11, 2020, three months after the letters
were mailed. Through an e-mail and face-to-face conversations, providers and staff at the
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primary care practice were apprised of the plan in anticipation of questions from patients
receiving letters.
The scheduling department scheduled DXA scans at one of the three aforementioned sites
through patient phone calls. After DXA scans were read by one of the hospital radiologists,
results were routed to the DNP student through the EMR. Beginning four weeks after the letters
were mailed, one reminder phone call was made if a DXA result was not apparent in the EMR.
The DNP student and one of the practice’s medical assistants made reminder phone calls to
patients. Some of the patients were reminded in person during a visit prior to November 12, 2019
and did not receive a phone reminder. Patients who were scheduled for appointments during
November 12-25, 2019 were reminded about the DXA invitation at their visits rather than over
the phone. A portion of patients did not receive a phone reminder for other reasons, such as
evidence they had moved out of the area or no longer came to the practice, had acute changes in
health such as a new cancer diagnosis, or previously unseen DXA records were located or
received.
Phase II. The second phase of the project began as patients receiving DXA scans were
informed of results. The DNP student communicated DXA results in the form of a mailed letter,
drafted in the style of a letter optimized by Edmonds et al. (2014), to those with normal bone
density or a diagnosis of osteopenia with average risk of fracture (Appendix E). Edmonds et al.
(2014) developed a letter based on the feedback from participants aged 50 and over. Participants
preferred a letter that gives the date of the DXA scan, explanation of T-scores, diagnosis, FRAX
score and a paragraph with lifestyle measures. The bar graph depicting fracture risk was also
adopted from Edmonds et al. (2014) for this project.
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Patients with a new diagnosis of osteopenia with a high risk of fracture or osteoporosis
were identified as needing medication treatment. Osteopenia with high risk of fracture is defined
by a T-score greater than -2.5 on DXA but a major risk of fracture greater than or equal to 20%
and/or a risk of hip fracture 3% or greater on FRAX. Several guidelines (ACOG, 2012; Camacho
et al., 2016; Cosman et al., 2014; Eastell et al., 2019; Lim et al., 2009) recommend treating
osteopenia with high fracture risk with osteoporosis medication. All patients who required
treatment counseling were called by the DNP student and offered an office visit to discuss
treatment options; patients were given the choice of meeting with the DNP student or their
primary care physician. Those who declined an appointment were given brief treatment
counseling over the phone. The DNP student also updated the EMR problem list for all patients
who had evidence of bone loss on DXA scan with diagnoses of osteopenia, osteopenia with high
risk of fracture or osteoporosis.
Counseling for treatment options included face-to-face discussion and two handouts, and
followed the ACP (Qaseem et al., 2017), Endocrine Society (Eastell et al., 2019), ACOG, NOF,
and AACE/ACE treatment guidelines. Patient education material was gleaned from the above
guidelines, which mainly agreed on general treatment measures. The counseling content included
facts about the development of thinning bones, calcium supplementation recommendations,
medication advice tailored to the patient’s history and preferences, suggestions for weightbearing exercise and/or balance improvement, and lifestyle changes applicable to the patient. The
handouts, drafted by the DNP student, were entitled, “Important Facts About Bone Health”
(Appendix F) and “Medication Options for Treating Osteoporosis” (Appendix G). Each handout
included journal and online references.
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The counseling topics also aimed to address all of the items on an abbreviated version of
the Osteoporosis Knowledge Assessment Tool (OKAT) (Winzenberg, Oldenburg, Frendin, &
Jones, 2003), which was used to measure the effectiveness of treatment counseling during the
office visits. The tool was administered before and after the visit (Appendix H). Permission to
use the OKAT in this project was gained from the principal investigator. The OKAT was
developed in Australia, first validated in young white females and later tested in other
populations around the world. The inventory presents 20 true or false statements, including,
“Osteoporosis usually causes symptoms (e.g. pain) before fractures” and, “Calcium supplements
alone can prevent bone loss.” The first 15 items of the inventory were used for this project. Only
one change was made to the wording; for the item, “Ragi and broccoli are good sources of
calcium for people who cannot take dairy products,” the term “ragi” was replaced with
“sardines” to give an example of a food that is more familiar to American participants. Scores
were calculated as the number of items correct and were compared before and after the
counseling visit for each patient.
When patients arrived for their visit, the medical assistant gave the patient the
abbreviated OKAT tool to complete. At the start of the visit, the patient was informed they
would be quizzed again on their knowledge of bone health. After completing the OKAT, the
medical assistant collected the OKAT tool and gave the patient the “Important Facts About Bone
Health” handout, allowing them to read it before the DNP student entered the exam room.
During the visit, the DNP student gave the patient the handout entitled, “Medication Options for
Treating Osteoporosis,” highlighting potential side effects to help patients weigh risks and
benefits of treatment. At the end of the visit, the patient was given another blank OKAT tool to
complete. If the patient agreed to medication, a prescription for alendronate was sent to the
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patient’s pharmacy, or an investigation of insurance coverage of IV bisphosphonates was
initiated.
Post-intervention. The number of DXA scans, results of DXA scans in T-scores, FRAX
scores, OKAT pre- and post-test scores, and number of patients starting osteoporosis medication
were recorded during the three-month intervention period.
Data Analysis
This quality improvement project adopts a one-group, pre-test/post-test study design. The
main outcome measurement is the percentage of participants receiving a DXA scan as a result of
the intervention; descriptive statistics compared the percentages of applicable patients receiving
appropriate screening three months prior to the intervention compared with three months after
the intervention. Descriptive statistics were also used to depict the results of completed DXA
scans. Percentages of patients with normal bone density, osteopenia, osteopenia and high risk of
fracture, and osteoporosis were compared. Additionally, numbers of patients receiving DXA who
started medication treatment during the intervention period were calculated. Average scores on
the OKAT before and after the treatment counseling sessions were compared using descriptive
statistics due to the small number of patients in this group.
Cost-Benefit Analysis
The cost-benefit analysis takes into account that 284 patients were mailed letters and that
69 of the contacted patients followed through with a DXA scan during the 3-month intervention
period. Costs include physical materials and personnel time (see Appendix I). Additionally, the
expense of the DXA scan services was covered by patients’ health insurance providers. Co-pays
and agreed reimbursement rates between insurers and the hospital may vary and cannot be
calculated for the purposes of this analysis. The estimated cost of the project is $13,562. Since
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the average cost of hospitalization following a hip fracture is between $19,000 and 31,000, this
project produces a cost savings, even if only one hospitalization is prevented (Burge et al., 2007).
Ethical Considerations/Protection of Human Subjects
The University of Massachusetts, Amherst (UMass) Internal Review Board (IRB)
approval was obtained prior to initiating this project (see Appendix J). This project is a quality
improvement study and the IRB did not classify the potential participants as human subjects; no
consent forms were needed. However, since the project involved protected health information,
all work involving patient data was done on an encrypted laptop provided by the primary care
practice. A password-protected Excel file containing patient information was stored on the
hospital intranet. Risks to participants included possible unnecessary testing, out-of-pocket
expenses, and exposure to a minor amount of radiation from a DXA scanner. Potential benefits
to participants included earlier treatment of bone loss, prevention of fracture and increased
knowledge of bone health.
Results
This intervention took place at a hospital-affiliated suburban primary care practice with
three PCPs. Participants were patients aged 50 and over who were eligible for osteoporosis
screening; this included all women in the practice aged 50 and over, all men aged 70 and over,
and men aged 50 and over with a prior diagnosis of bone loss.
Participants
A total of 979 patients were included in the sample. The vast majority (90.8%) of patients
identified as Caucasian and non-Hispanic/Latinx, followed by 6.5% Asian, 0.6% Caucasian and
Hispanic/Latinx, 0.6% African-American and 0.1% multiracial, while the rest of patients were of
unknown race (1.3%). The sample was 74.4% female and 26.6% male.
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After a list of 324 eligible patients was presented to the practice’s PCPs, 38 patients were
removed because the PCP thought the patient would not comply with screening, the patient
should not receive osteoporosis medication or that screening was a low priority because of
advanced age or medical issues. A total of 284 letters were sent, but after further review of
records, 23 were removed from the denominator because the patient was either already up to date
with DXA screening, had changed practices, was already receiving treatment, or was deceased.
Of the 261 patients who correctly received letters, 67 (25.6%) had a DXA scan during the three
months after the intervention. Two more patients who received letters also had a DXA, but they
had a prior scan less than five years before the intervention and should not have been mailed a
letter. Ten patients had a DXA scan ordered by their PCP within the three months before the
intervention and did not receive letters.
Of patients who were sent an invitation letter, qualifying reasons for receiving a letter are
depicted in Table 1. Nine of the patients who had DXAs were invited for screening only because
they had osteopenia on prior imaging. Of these, five had osteopenia, two had osteopenia with
high risk of fracture, one had osteoporosis and one had normal bone density.
Table 1
Numbers and Percentages of Patients Sent Letters by Qualifying Reason for Screening
Sent Letters
Qualifying Reason for Invitation Letter

(n)

(%)

Prior history of osteoporosis

17

6.5

Prior history of osteopenia with high fracture risk

2

0.8

Prior history of osteopenia

40

15.3

History of fracture and no DXA

18

6.9

IMPROVING OSTEOPOROSIS SCREENING RATES

27

Osteopenia on imaging and no DXA

34

13.0

Females 50-64 and OST < 1.0

38

14.6

Females aged >65

37

14.2

Males aged >70 with OST < 3.0

75

28.7

Total

261

100

For those who completed a DXA scan, reasons for receiving an invitation letter are
shown in Table 2. Over a third (37.3%) of those who had a DXA as a result of the intervention
were men over age 70 with an OST score less than 3.0. Men made up 28.7% of the recipients of
the letters and were thus overrepresented in the group who completed DXA screening.
Table 2
Numbers and Percentages of Patients Who Had DXA by Qualifying Reason for Screening
Completed
DXA (n)
3

Completed
DXA (%)
4.5

Prior history of osteopenia with high fracture risk

0

0

Prior history of osteopenia

9

13.4

History of fracture and no DXA

6

9.0

Osteopenia on imaging and no DXA

9

13.4

Females aged 50-64 and OST < 1.0

9

13.4

Females aged >65

6

9.0

Males aged > 70 with OST < 3.0

25

37.3

Total

67

100

Qualifying Reason for Invitation Letter
Prior history of osteoporosis
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As shown in Table 3, a majority (70.1%) of the 67 completed DXA scans showed a
diagnosis of bone loss. Twenty of 67 (29.9%) scans showed normal bone density.
Table 3
Diagnoses Revealed by DXA Scans During the Intervention
Diagnosis

n (%)

Osteopenia

25 (37.3%)

Osteopenia with high risk of fracture

8 (11.9%)

Osteoporosis

14 (20.9%)

Normal bone density

20 (29.9%)

Total

67 (100%)

The eight patients whose DXA showed osteopenia and high risk of fracture and the 14
patients with osteoporosis were invited for visits; 11 of the patients had an office visit, while four
had appointments with their PCP to discuss treatment options, and seven patients declined
appointments and received counseling over the phone.
Sensitivity and Specificity of OST Scores
An OST score of less than 1.0 for women and less than 3.0 for men correctly predicted a
T-score of -2.0 or less in 23 of 55 (41.8%) patients. OST scores of greater than or equal to 1.0 in
women and greater than or equal to 3.0 in men correctly predicted T-scores of -2.0 or greater in
11 out of 12 (91.7%) patients. However, the OST score less than 1.0 for women and less than 3.0
for men correctly predicted any bone loss (T-score of -1.0 or less) for 40 out of 55 (72.7%)
patients, while it ruled out bone loss in 4 out of 12 (33.3%) of patients.
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DXA Screening Rate
Three months prior to the intervention, the practice had appropriately screened 398 of the
716 applicable patients, whereas three months after the intervention, the practice had screened
475 of the applicable patients. Ten of the 475 patients had DXA scans during the three months
prior to the intervention, ordered by the practice’s PCPs and independent of the intervention.
Table 4 shows the number and percentage of patients by age and is inclusive of those with prior
diagnoses of bone loss. Table 4 also demonstrates the popularity of the intervention among men
over 70, and that the greatest gains of the intervention were made in that demographic.
Table 4
Numbers and Percentages of Patients Screened Before vs. After Intervention, by Age Group
Three Months Before
Intervention
Age group

Three Months After
Intervention
Total (n)

(n)

%

(n)

%

Women aged 50-64

65

47.1

80

57.9

138

Women aged >65

263

70.3

286

76.5

374

Men aged 50-69

9

81.8

10

90.9

11

Men aged > 70

61

31.6

99

51.3

193

All groups

398

55.6

475

66.3

716

Note. Men aged 50-69 in the sample all have a prior diagnosis of bone loss.
Table 5 shows the difference between the screening rates three months before and three
months after the intervention among patients with a prior diagnosis of bone loss, history of
fracture or evidence of osteopenia incidentally noted on imaging. In this analysis, patients were
coded as having osteoporosis if ever diagnosed with osteoporosis, even if subsequent DXA scans
improved.
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Table 5
Numbers and Percentages of Patients with Prior Evidence of Bone Loss Appropriately Screened
Before and After the Intervention
Three Months
Before Intervention

Three Months
After Intervention

(n)

%

(n)

%

Total
(n)

Prior osteoporosis diagnosis

121

84.6

124

86.7

143

Prior osteopenia with high fracture
risk diagnosis

41

91.1

42

93.3

45

Prior osteopenia diagnosis

164

77.0

177

83.1

213

Prior history of fracture without DXA

0

0

7

25.9

27

Osteopenia on imaging and no DXA

0

0

9

19.6

46

326

68.8

359

75.7

474

Diagnosis

All diagnoses

In this group, the intervention was useful in getting patients with osteopenia to update
their DXA scans, and also prompted several patients with a history of fracture to be screened,
which was likely missed when the fracture initially occurred.
Impact of Reminder Calls
During the three-month intervention period, 111 of the 261 patients had appointments at
the primary care practice. Providers reminded patients about the recommendation to schedule a
DXA at 34 of these appointments. One month into the intervention, 149 reminder calls were
placed. Of the 67 patients who had a DXA during the intervention period, four required
prompting at an appointment, while 33 required a reminder call.
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Medication Initiation
As a result of the intervention, four of the 11 patients who had office visits were started
on an oral bisphosphonate (alendronate), while two agreed to start on an IV bisphosphonate
(zoledronic acid). Of the 22 patients who were eligible for medication, seven agreed (one of
whom was seen by her PCP), ten declined, four were undecided and one patient deferred
discussion until a routine visit later in the year.
Three months prior to the intervention, 45 patients had a known diagnosis of osteopenia
with high risk of fracture. Eight of them had a prior history of taking osteoporosis medication, 18
were currently under treatment and 19 were never treated. Within the three months prior to the
intervention, one more patient had a DXA scan revealing osteopenia with risk of fracture and
was treated. See Tables 6 and 7 for the comparison of treatment rates three months prior to the
intervention with rates three months after.
Table 6
Numbers and Percentages of Treatment-Eligible Patients in Practice Taking Osteoporosis
Medication, Three Months Before Intervention

Diagnosis

History of
Past
Treatment
(n)

Under
Current
Treatment
(n)

Osteopenia with high fracture risk

8

Osteoporosis
Total

Total Treated

Total
TreatmentEligible
Patients
(n)

(n)

%

18

26

57.8

45

45

53

98

68.5

143

53

71

124

65.9

188

As a result of the intervention, 8 additional patients were diagnosed with osteopenia with
high fracture risk; however, one of them had a previous diagnosis of osteoporosis and is

IMPROVING OSTEOPOROSIS SCREENING RATES

32

therefore coded as having osteoporosis for this analysis. One of the 8 patients started treatment,
three were undecided and four declined to start medication.
As shown in Table 6, a known 143 patients had a known history of osteoporosis three
months prior to the intervention. Within the three months prior to the intervention, two patients
had a new osteoporosis diagnosis and began treatment. During the intervention, fourteen of the
patients had DXAs showing osteoporosis, twelve of which were new diagnoses. Six of these 14
patients agreed to treatment, 5 declined and 3 were undecided. The medication initiation rate was
7 out of 22 (31.8%).
Table 7
Numbers and Percentages of Treatment-Eligible Patients in Practice Taking Osteoporosis
Medication, After Intervention

Diagnosis

Treated as of
1/15/20
(n)
%

(n)

%

Treatment-Eligible
Patients as of
1/15/20
(n)

Never Treated

Osteopenia with high fracture risk

28

52.8

25

47.2

53

Osteoporosis

105

67.7

50

32.3

155

Total

133

63.9

75

36.1

208

As seen in Table 7, the percentage of treatment eligible patients who had ever taken
medication declined from 65.9% prior to the intervention to 63.9% after the intervention. The
medication initiation rate of the patients having DXA scans during the intervention (31.8%) was
lower than the rate of patients agreeing to medication in the practice in general prior to the
intervention (65.9%).
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Assessment of Improvement in Osteoporosis Knowledge
The average number of items answered correctly on the OKAT tool was 5.55 (SD = 3.3)
prior to the counseling visit compared with 10.18 (SD = 2.2) items after the visit. Table 8
illustrates the number of patients who answered each item correctly in the pre-test OKAT and
post-test OKAT.
Table 8
Percentage of Patients with Correct Answer on OKAT Tool Pre-test vs. Post-test, by Item

Percent with
Correct Answer
Pre-test (%)

Percent with
Correct Answer
Post-test (%)

Change in
Number of
Correct Items
(%)

1. Osteoporosis leads to an increased risk of
bone fractures. (True)

100

100

0

2. Osteoporosis usually causes symptoms
(e.g., pain) before fractures occur. (False)

36.3

81.8

45.5

3. Having a higher peak bone mass at the
end of childhood gives no protection
against the development of osteoporosis
in later life. (True)

0

54.5

54.5

4. Osteoporosis is more common in men.
(False)

54.5

100

45.5

5. Cigarette smoking can contribute to
osteoporosis. (True)

45.5

100

54.6

6. White women are at highest risk of
fracture when compared with other races.
(True)

9.1

63.6

54.5

7. A fall is just as important as low bone
strength in causing fractures. (True)

45.5

45.5

0

8. By age 80 years, a majority of women
have osteoporosis. (True)

45.5

72.7

27.2

Item (Correct Answer)
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9. From age 50 years, most women can
expect at least one fracture before they
die. (True)

27.3

45.5

18.2

10. Any type of physical activity is beneficial
for osteoporosis (False)

45.5

54.5

9.0

11. It is easy to tell whether I am at risk of
osteoporosis by my clinical risk factors.
(True)

45.5

72.7

27.2

12. Family history of osteoporosis strongly
predisposes a person to osteoporosis.
(True)

54.5

72.7

18.2

13. An adequate calcium intake can be
achieved from two glasses of milk a day.
(True)

18.1

54.5

36.4

14. Sardines and broccoli are good sources of
calcium for people who cannot take dairy
products. (True)

54.5

63.6

9.1

15. Calcium supplements alone can prevent
bone loss. (False)

27.2

63.6

36.4

While the number of patients completing the OKAT tool was small (n=11), a few
patterns emerged. Item 1 was universally answered correctly before and after the intervention,
meaning that the item was likely too easy for this population and perhaps should not be included.
The items related to calcium sources (items 13 and 15) showed improvement as this was a focus
of the counseling. There was no improvement in knowledge about the importance of falls; it was
not directly covered in the educational handouts. Of note, the instrument was set up with “I don’t
know” as an answer, making it less likely for participants to make an educated guess.
Timeline
A summary of the project timeline can be found in Appendix K. After project approval
on August 13, 2019, data from the EMR was examined to determine eligible participants for the
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study. Eligibility lists were reviewed by the practice’s PCPs the week of September 30, 2019.
The scheduling department received DXA orders for eligible participants October 8, 2019.
Letters were mailed at the end of the business day on Friday, October 11, 2019. As the following
Monday was a national holiday, the intervention start date was Tuesday, October 15, 2019; this
is the first business day that patients could call to schedule a DXA scan. Starting the week of
November 11, 2019, patients without evidence of a DXA scan were reminded by phone. The
reminder calls took three weeks. Over a period of three months, numbers of DXA scans, their
results and treatment decisions were recorded. The last DXA scans included in the analysis took
place on January 15, 2020.
Discussion
Phase I of this intervention, involving mailing patient letters inviting them to schedule
DXA screening, was successful in encouraging 25.6% (n=67) of the patients to schedule a DXA
scan within a three-month period. The practice’s screening rate increased from 55.6% three
months prior to the intervention to 66.3% three months after the intervention, which is an
increase of 19.2%, short of the goal of 25%. However, even after the intervention period ended,
DXA scans continued to be completed. Reminder calls were shown to be effective; about half of
those who scheduled a scan did so after a phone call. As expected, the majority (70.1%) of the
DXA scans showed bone loss, validating the procedure for selecting patients for a DXA
invitation. Phase II involved 45 results letters and 11 counseling visits with the DNP student.
During the counseling visits, patients demonstrated improvement in their osteoporosis
knowledge as evidenced by an improvement in OKAT scores before and after the visits. The
improvement from 5.55 (SD = 3.3) correct answers to 10.18 (SD = 2.2) demonstrated an 84.3%
improvement, short of the goal of 100%. While some patients agreed to take medication, most

IMPROVING OSTEOPOROSIS SCREENING RATES

36

declined or were undecided. The medication initiation rate was 31.8%, below the 50% goal. The
practice’s medication initiation rates actually decreased from 3 months before to 3 months after
the intervention.
In terms of this project’s theoretical framework -- the Stetler model -- the fifth phase,
evaluation, is a reflection of the application/evidence translation done by the intervention. While
the intervention was mostly successful, there were aspects that could be done differently if such a
population health effort were repeated. Additionally, reflecting on the interventions successes
reveal lessons that can be used in everyday practice.
Successes of the Project
This was a simple intervention of low direct cost to the practice. Similar to quality
improvement efforts involving reminder letters to patients to schedule mammograms or
colonoscopies, this QI project could easily be replicated at a primary care practice. It was
demonstrated that the effect of such a mailing would be bolstered by phone calls as well as
prompting by providers. Patient compliance with the DXA recommendation does require that the
patient be somewhat familiar with osteoporosis or bone density screening in the first place; this
starts during preventative care visits.
Even if patients did not agree to a DXA scan or medication during the three-month
intervention period, it opened up conversations between patients and providers about lifestyle
recommendations, screening and medication options. Physicians in the practice demonstrated
these conversations in their progress notes during the intervention period. Additionally, initial
improvements in the screening rate have the potential to maintain higher screening rates moving
forward. For those with a new diagnosis of bone loss, providers will likely recheck DXA scans
on many of these patient in the next several years. Additionally, with an osteopenia or
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osteoporosis diagnosis added to the problem list, providers will be reminded to address these
diagnoses at preventative care visits.
This intervention was particularly popular with men over age 70. The level of
improvement may reflect the practice’s overall under-screening of bone loss in older men.
Specifically, many of the men who had never been screened were willing to have a DXA but had
never been advised to do so. In contrast, DXA screening in women is more common, so many of
the women who received letters in this intervention may have represented a group less compliant
with routine recommendations, and an invitation letter would have been relatively ineffective at
creating a change in behavior.
The OST thresholds used in this project showed a sensitivity of 72.7% in detecting any
bone loss (T score of -1.0 or less), though the OST sensitivities calculated in Nayak et al. (2015)
assume a T-score of -2.0 or less. This project, though using a relatively small sample, supports
the use of OST in clinical practice. It requires only age and weight to calculate the OST score,
whereas other fracture risk tools require more data that may not be readily available in the EMR.
Additionally, the OST may easily be added into an EMR function for clinical decision support.
This practice’s EMR already has a calculator tool for predicting an atherosclerotic cardiovascular
disease (ASCVD) score based on several variables pulled from EMR data.
Counseling sessions used evidence-based practice to answer common questions but also
well-tailored to individual patient concerns and medical histories. Patients expressed that they
had learned useful information in the counseling session, even if they decided not to take
medication. Some patients showed that they are more willing to take calcium supplements and
were not aware that taking a calcium supplement with magnesium can help counteract
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constipation. The medication and lifestyle education handouts continued to be used after the
intervention period ended.
Lessons Learned
While the reminder calls were useful, they were very time consuming. The planned
protocol was to remind patients over the phone to complete the scan one month after the letter
was sent. This took one week longer than expected; the calls took place from November 12-25
and one of the practice’s medical assistants was recruited to help call the patients. When the
DNP student called, patients often had questions about screening or unrelated issues, taking up
time on the phone. Calls were faster when done by the medical assistant, who was able to triage
patient questions back to the DNP student or PCPs if needed.
Chart reviews revealed missed opportunities for treatment. Prior to the project, a new
diagnosis of bone loss was often not added to the problem list in the patient’s chart after a DXA
scan was read. The items in a problem list serve as a prompt in creating an assessment and plan
during a visit; without the item in the problem list, the diagnosis is more easily ignored.
Additionally, prior to the intervention, result letters were often sent to these patients without
proper follow up; a more proactive plan would be to communicate directly with the PCP to tell
them that the patient is pending a decision about medication or that a letter/voicemail was sent.
In this practice, an EMR flag can be scheduled ahead of time to send to the PCP just prior to
their next appointment.
Chart reviews also came with an unexpected finding: some patients had a diagnosis on
their problem list, “osteopenia determined by x-ray.” This diagnosis was chosen if an x-ray or
CT scan showed an incidental finding of an “osteopenic” appearance (as worded by the
interpreting radiologist), but a DXA was not available for validation. As a result, all chart
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reviews included an assessment of all available x-ray and CT records to find mention of
osteopenia in the interpretation. For this project, “osteopenia on imaging” became its own
eligibility criterion. Although x-ray is not used in the diagnosis of osteopenia or osteoporosis,
McCullagh, McCoy, Crawford, and Taggart (2003) showed that of individuals with a spinal xray showing signs of osteopenia, 49.2% had osteopenia (T-score -1 to -2.5) on a DXA scan,
while 38.1% had osteoporosis (T-score <-2.5) on DXA. In this intervention, nine of the patients
who had DXAs based on osteopenia on prior imaging, and only one had normal bone density. In
the future, one could consider screening patients if x-ray reports state “decreased mineralization”
in the interpretation; such patients were not included in this intervention.
Widening the inclusion criteria to screen patients with a history of fracture for bone loss
provided a form of secondary fracture prevention that was similar to work done by fracture
liaison teams (Wu et al., 2018). Screening these patients may have opened up the conversation
about osteoporosis treatment that was not discussed in the acute phase of fracture treatment or
forgotten. However, the location of the previous fracture matters. Those with rib and ankle
fractures in this sample of patients had DXA scans showing normal bone density, while patients
with a history of femur and vertebral fractures had DXA scans showing osteoporosis. A
retrospective cohort study showed that lower leg fractures, including foot, ankle, tibia and fibula
fractures were the lowest predictor of future fracture, while hip and femur fracture were the most
predictive of future fractures (Beaudoin et al., 2018). This knowledge helps the provider
prioritize osteoporosis screening in patients with hip fractures. If this type of intervention were
repeated, providers should focus their efforts in screening those with hip and femur fractures.
The decreased medication initiation rate was a surprising result. A possible reason for this
was the nature of the medication counseling. In order to help patients to make informed decisions
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about treatment, the counseling heavily focused on drawbacks and potential side effects, perhaps
not fully illustrating the benefits of reduced fracture risk. Another reason was that patients in the
practice who have previously tried osteoporosis medication were mostly counseled by their
PCPs, with whom they had built a trusting relationship. Some of the patients who presented for
counseling in this intervention had never met the DNP student before their visit. If this were the
case, it may have given more legitimacy to the advice to state during the visit, “I showed these
results to your PCP and they agree with the recommendation that you start medication.”
Project Facilitators and Barriers
Within this setting, the providers are very supportive of osteoporosis screening, which
facilitated the intervention. The DNP student who ran the intervention has been working at the
practice for seven years and has a good rapport with many of the patients; receiving a letter from
a familiar person may have given credibility to the recommendation to have a DXA scan.
Logistics were also made easier with the support of the practice and hospital staff. Specifically,
permission from the hospital’s population health team has been granted to use a software tool
called IBM Watson. This tool has already been programmed to search EMR data to generate lists
of patients (women over 65 and men over 70) who have not had DXA scans in the last two years.
The hospital’s marketing team was also supportive in proofreading the invitation letter and
printing the educational brochures.
Barriers to this intervention was the relatively low patient prioritization of bone density
screening as well as patients’ low perceived risk of fracture. A relatively low number of the
practice’s patient interactions during the intervention period included a discussion about
scheduling a DXA scan. There were many overlooked opportunities to remind patients during
office visits to schedule a DXA; handling acute symptoms often took priority at sick visits.
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Another possible barrier was the generic form letter that did not give patients any specific reason
why they should be screened. More individual feedback about risk factors may have been more
motivating for patients to schedule a DXA scan.
The goal of the patient education included with the letters is to raise awareness of fracture
risk. Even for patients who are aware of fracture risk and agree to DXA screening, osteoporosis
medications have received negative publicity due to rare adverse events, and this is a barrier to
starting treatment for some patients. Fear about medication risks is one of the main reasons for
the osteoporosis treatment gap in general. Compston (2020) also points out that the treatment gap
for osteoporosis is fueled by 1) the fact that osteoporosis is treated by a variety of specialties,
making it unclear who is “in charge” of the patient’s treatment and 2) the inconsistency between
treatment guidelines is confusing and reduces their credibility.
Nursing Implications
The nurse practitioner, particularly in the areas of adult-gerontology, women’s health and
endocrinology, has the challenge of addressing bone health in patients 50 and over, even when
more pressing diagnoses take priority. One reason this is a challenge is the asymptomatic nature
of bone loss. However, nurse practitioners can advocate for primary prevention of bone loss and
fracture and secondary prevention with appropriate screening. Some nurse practitioners are
already functioning as fracture liaison providers, but nurse practitioners at large are at the
forefront of patient education; they should keep themselves educated about lifestyle
recommendations for their patients over 50 as well as medication options for treating
osteoporosis. Nurse practitioners also need to keep updated on screening guidelines, though
national guidelines do not always agree.
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Conclusion
DXA screening in older women and men is underutilized despite the advice of several
national guidelines. This quality improvement project identified older adults at highest risk of
fracture and increased osteoporosis screening rates in a primary care practice with a simple, lowcost intervention. The results of this project were consistent with the current evidence that
interventions including letters inviting eligible patients to self-refer for DXA screening have
been effective at increasing bone density screening, especially if paired with a reminder phone
call. The intervention did show some improvement in osteoporosis knowledge in those who
received counseling, but failed to improve medication initiation in this patient population. In
order to maintain the successes of the project, the practice may need to place more importance on
bone density screening and integrate it with other population health screening efforts, such as
those for colonoscopies or mammograms. An effort to educate other providers about the OST’s
usefulness as a screening tool, as well as the utility of following up with a DXA if osteopenia is
noted on imaging results, also may clarify who needs to be screened for osteoporosis. Such
efforts must start with increased awareness of the providers in the practice and a willingness to
treat bone density screening as a clinical priority.
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Appendix A
Summary of Osteoporosis Screening Guidelines

Guideline

Women
≥ age 65

Postmenopausal
women with risk
factors
Men ≥ age 70

Men age 5069 with risk
factors

American Academy of Family
Physicians (AAFP)

X

X

Insufficient
evidence

Insufficient
evidence

American College of Preventative
Medicine (ACPM) (Lim et al., 2009)

X

X

X

X

American College of Obstetrics and
Gynecology (ACOG)

X

X

N/A

N/A

Association of Clinical
Endocrinologists (AACE) /
American College of Endocrinology
(Camacho et al., 2016)

X

X

N/A

N/A

American College of Physicians
(Qaseem et al., 2008)

N/A

N/A

Only with
risk factors

X

The Endocrine Society (Watts et al.,
2012)

N/A

N/A

X

X

International Society for Clinical
Densitometry (ISCD) (ISCD, 2015)

X

X

X

X

National Osteoporosis Foundation
(NOF) (Cosman et al., 2014)

X

X

X

X

North American Menopause Society
(NAMS)

X

X

N/A

N/A

United States Preventive Services
Task Force (USPSTF, 2018)

X

X

Insufficient
evidence

Insufficient
evidence
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Appendix B
Stetler Model of Research Utilization to Facilitate EBP, Part I (Stetler, 2001)
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Appendix C
Sample of Letter to Eligible Patients

Date
Patient Name
Patient Address Line 1
Patient Address Line 2

Dear Mr./Ms. ________________,

At [name of our practice], we are working to improve care for patients who may be at risk for
osteoporosis, which is a condition leading to thinning of the bones. This condition may result in
debilitating fractures. Based on information from our electronic medical records, you have one or
more risk factors for bone loss. Our recommendation is that you schedule a low-radiation scan
called DXA.
We have enclosed a brochure with information on osteoporosis and DXA scans for your review.
You may call to schedule a DXA scan through Central Scheduling at [Name of Hospital] at
[phone number]. The test is available at the main hospital and [names of two outpatient
centers].

Sincerely,

Heidi Doreau NP

[Names of PCPs]
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Appendix E
Sample DXA Results Letter
Name
Address Line 1
Address Line 2
Date
Dear Mr./Ms. _____________,
The following are the results of your bone density (DXA scan) done on [date]. DXA
scanners report bone density as a T-score. This score is a comparison of your bones to those of
young adults, when bones are strongest. Your T-score is _____, which means that your bone
density [is normal / shows osteopenia]. According to the World Health Organization’s fracture
risk assessment tool FRAX, your risk of a fracture in your spine, forearm, shoulder or hip in the
next ten years is _____, while your risk of
fracturing a hip is _____.
Your bone health can be
[maintained/improved] with minimizing caffeine
and maximizing weightbearing exercise. Also,
you can supplement your diet with calcium
citrate 1200mg and vitamin D3 1000 units per
day. [If osteopenia: “We plan to recheck your
bone density in 5 years.”] If you have questions
about your results, please contact our office.

Sincerely,

Heidi Doreau NP

[Name of PCP]
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Appendix F
Patient Diet and Lifestyle Education Handout (Page 1)
Important Facts about Bone Health
Osteoporosis is a common condition that leads to thinning of the bones and increased risk of
fractures. Osteopenia is bone loss to a lesser degree than osteoporosis, but may lead to
osteoporosis one day. Bone loss causes only one symptom: fracture, particularly with minimal
trauma.
● Children and young adults who exercise achieve a higher peak bone mass than those who
are sedentary. Additionally, exercise can help adults prevent bone loss. Such exercises
include weight-bearing (walking, jogging, climbing stairs) and resistance exercises
(exercise machines, weightlifting).
However: Those with severe osteoporosis should use caution with lifting heavy
weights, bending at the trunk, and rotating the spine side to side as these
movements may lead to compression fractures of the spine.
● By age 70, over half of women have bone loss requiring medication.1 1 in 3
postmenopausal women will have an osteoporotic fracture in her lifetime.2
● About 19% of men over 50 have bone loss requiring medication1 and 1 in 5 men over 50
will have a fracture in his lifetime.2
● The majority of fractures occur in those with a diagnosis of osteopenia as this is a more
common condition than osteoporosis.
● Vertebral fracture is the most common type of osteoporotic fracture.3
Risk factors for bone loss include:
● Being female, particularly after menopause
● Low testosterone in men
● Being Caucasian
● Cigarette smoking
● Drinking more than 3 alcoholic beverages daily
● Rheumatoid arthritis
● Family history of osteoporosis
● Taking certain medications, such as oral steroids
Prepared by Heidi Doreau NP
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Appendix F (Continued)
Patient Diet and Lifestyle Education Handout (Page 2)
Diet Recommendations for Optimizing Bone Health
● Calcium supplements alone have a modest ability to reduce fractures: about 15%.4
● Your goal is to consume at least 1200mg of calcium per day,3 preferably from your diet.
An 8 ounce glass of milk has 300mg.5 Nondairy source of calcium include sardines,
broccoli, spinach, seeds, beans, and almonds.
● If you cannot get enough calcium in your diet, take calcium supplements. Pills with
calcium citrate are best absorbed.
● Most calcium supplements come with vitamin D3, but you may need an additional
vitamin D3 supplement to get the daily recommended 1000-2000 units. The daily upper
limit of vitamin D3 is 4000 units.6
● Calcium can be constipating. Taking a calcium pill containing magnesium may help
counteract constipation.
● Protein is also important for bone health: eggs, fish, chicken, beans, nuts, yogurt, cottage
cheese.
● Caffeine intake recommended not to exceed 1-2 servings per day.4
● Soy supplements do not have a significant effect on bone density.6
References
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https://www.iofbonehealth.org/facts-statistics#category-14
3. Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., …
Watts, N. B. (2016). American Association of Clinical Endocrinologists and American
College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment
of Postmenopausal Diagnosis. Endocrine Practice, 22(4), 1-42.
4. Weaver, C.M., Alexander, D.D., Boushey, C.J., Dawson-Hughes, B., Lappe, J. M.,
LeBoff, M.S., … Wang, D.D. (2016). Calcium plus vitamin D supplementation and risk
of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
Osteoporosis International, 27(1), 367-76.
5. U.S. Department of Agriculture. (2019). FoodData Central. Retrieved from
https://fdc.nal.usda.gov/fdc-app.html#/food-details/336072/nutrients
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and Gynecologists (2012). ACOG Practice Bulletin N. 129. Osteoporosis. Obstetrics &
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Appendix G
Patient Handout Summarizing Medication Options
Medication Options for Treating Osteoporosis
● Alendronate (Fosamax) - most effective of the oral bisphosphonates
○ Pill taken once a week
○ Alendronate reduces:
■ vertebral fractures by 44%
■ hip fracture by 40%
■ nonvertebral fractures by 17% (Eastell et al., 2019).
○ Usually given for 5 years but can be used for 10 years in severe cases
○ Common side effects include acid reflux and stomach discomfort
○ Rare side effects include osteonecrosis of the jaw (ONJ) and atypical femur
fracture (AFF)
● Zoledronic acid (Reclast) is an IV bisphosphonate
○ Dose is 5 mg by intravenous infusion over at least 15 min once yearly
○ Usually given for 3 years (3 doses), but in severe cases up to 6 years
○ Over 3 years, zoledronic acid reduces:
■ vertebral fractures by 70% (with significant reduction at 1 year)
■ hip fractures by 41%
■ nonvertebral fractures by 25% (Cosman et al., 2014).
○ Potential side effects include muscular and joint pain; these mostly resolve within
3 days after treatment.
● Denosumab (Prolia) is a human monoclonal antibody - a “biologic agent”
○ Prolia reduces:
■ vertebral fractures by ~68%,
■ hip fractures by ~40%
■ nonvertebral fractures by ~20% over 3 years (Cosman et al., 2014).
○ Potential side effects include low calcium, cellulitis, rash, ONJ (rare), AFF (rare)
○ When discontinued, rapid bone loss results and should be immediately followed
by a bisphosphonate
References
Cosman, F. & de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay,
R. (2014). Clinician’s guide to prevention and treatment of osteoporosis. Osteoporosis
International, 25(10), 2359–2381. doi:10.1007/s00198-014-2794-2
Eastell, R., Rosen, C. J., Black, D. M., Cheung, A. M., Murad, M. H., & Shoback, D. (2019).
Pharmacological Management of Osteoporosis in Postmenopausal Women: An
Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology &
Metabolism, 104(5), 1595–1622. doi: 10.1210/jc.2019-002
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Appendix H
The Osteoporosis Knowledge Assessment Tool (OKAT)
Please answer each of the following questions with True, False or Don’t Know.
1. Osteoporosis leads to an increased risk of bone fractures.
2. Osteoporosis usually causes symptoms (e.g. pain) before fractures occur.
3. Having a higher peak bone mass at the end of childhood gives no protection against the
development of osteoporosis in later life.
4. Osteoporosis is more common in men.
5. Cigarette smoking can contribute to osteoporosis.
6. White women are at highest risk of fracture as compared to other races.
7. A fall is just as important as low bone strength in causing fractures.
8. By age 80, the majority of women have osteoporosis.
9. From age 50, most women can expect at least one fracture before they die.
10. Any type of physical activity is beneficial for osteoporosis.
11. It is easy to tell whether I am at risk of osteoporosis by my clinical risk factors.
12. Family history of osteoporosis strongly predisposes a person to osteoporosis.
13. An adequate calcium intake can be achieved from two glasses of milk a day.
14. Sardines and broccoli are good sources of calcium for people who cannot take dairy products.
15. Calcium supplements alone can prevent bone loss.
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Appendix I
Cost-benefit Analysis
Item

Cost
Data Collection and Analysis

Laptop with access to EMR, IBM Watson and
Excel software

Provided by the primary care practice

Printed & Mailed Materials
Letterhead for letters to patients, envelopes

$30 (provided by the primary care practice)

Educational brochures

$140 (printing paid by hospital)

Postage

$157 (paid by the primary care practice)
Personnel

DNP student as program coordinator for 2
semesters (6 credits)

$750 per credit = $4,500 (not included in
total costs for project)

Marketing staff (editing brochure) – 2 hours

$30 per hour x 2 hours = $60 (paid by the
hospital)

Central Scheduling (processing orders)
285 orders over 16 hour period

$25 per hour x 16 hours = $400 (paid by the
hospital)

Certified densitometry technologists
69 scans, totaling 18 hours

$25 per hour x 18 hours = $450 (paid by the
hospital)

Medical assistant (phone reminders)

$25 per hour x 4 hours = $100

Radiologists interpreting DXA results
69 scans, totaling 18 hours

$200 per hour x 18 hours = $3600 (paid by
the hospital)
Billable services

DXA scans
$125 per scan x 69 scans
Total estimated costs

$8625 (Paid by health insurance to the
hospital)
$13,562
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Project Approval by UMass Human Research Protection Office
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Appendix K
Project Timeline
Task

Aug
2019

Project
approval

X

Selection of
eligible
participants

X

Sept
2019

Oct
2019

X

X

DXA orders
sent to Central
Scheduling

X

Letters mailed
to eligible
participants

X

DXA scans
performed

X

Reminder
phone calls
Outcome
evaluation

Nov
2019

Dec
2019

Jan
2020

X

X

X

X

X

X

Feb
2020

Mar
2020

Apr
2020

X

X

X

